- Nachrichtendetail
-
02.05.2024 08:11:34 - dpa-AFX: *AZN : CALQUENCE COMBINATION REGIMEN SHOWS PFS IMPROVEMENT IN FIRST-LINE MANTLE CELL LYMPHOMA IN PHASE III TRIAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 145,450 | 23.05.24 10:44:02 | +0,250 | +0,17% | 145,350 | 145,500 | 145,600 | 145,200 |
